Loading insider details...
Beta
Latest Form 4 (Jul 10, 2026): Grant/Award of 50,000 MCRB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 10, 2026 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 50,000 | n/a |
| Mar 6, 2026 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 150,000 | n/a |
| Jul 17, 2025 | Longeveron Inc. (LGVN) | Grant/Award | 17,000 | n/a |
| Apr 11, 2025 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 100,000 | n/a |
| Jan 7, 2025 | BICYCLE THERAPEUTICS PLC (BCYC) | Grant/Award | 6,250 | n/a |
| Jun 21, 2024 | Omega Therapeutics, Inc. (OMGA) | Grant/Award | 50,000 | n/a |
| May 14, 2024 | Longeveron Inc. (LGVN) | Grant/Award | 16,000 | $23.3K |
| Apr 8, 2024 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 60,000 | n/a |
| Jan 4, 2024 | BICYCLE THERAPEUTICS plc (BCYC) | Grant/Award | 6,000 | n/a |
| Jun 23, 2023 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 35,000 | n/a |